Effect of discontinuation of ticagrelor and switching-over to other P2Y12 agents in patients with acute coronary syndrome: a single-center real-world experience from India

Effect of discontinuation of ticagrelor and switching-over to other P2Y12 agents in patients with acute coronary syndrome: a single-center real-world experience from India

Abstract Background Dual antiplatelet therapy is the current standard of care after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). We intended to study the pattern of use of ticagrelor in patients with acute coronary syndrome undergoing PCI and the effect of switching ov...

Full description

Bibliographic Details
Main Authors: Nagendra Boopathy Senguttuvan, Ramesh Sankaran, Yashasvi Rajeev, Devi Thaiyal, Angel Mathew, K. Dharsini, Divya Marcelene, Maria Jusler Kalsingh, Sujit Kumar Sahu, Aravind Sampath, K. J. Prem Kumar, Harikrishnan Parthasarathy, Amal Louis, Anand Gnanaraj, K. N. Reddy, K. A. Abraham
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:The Egyptian Heart Journal
Subjects:
Ticagrelor
Acute coronary syndrome
Bleeding
Clopidogrel
Switch over
Online Access:https://doi.org/10.1186/s43044-020-00128-3

Internet

https://doi.org/10.1186/s43044-020-00128-3

Similar Items